Company / Working Capital
AVADEL PHARMACEUTICALS PLC Working Capital History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$85.4M
FY2024
5-year range
$45.0M / $248.3M
FY2020-FY2024
Trend
-12.3%
vs FY2023
Sector context
#198 of 213
Health Care
What the data says
Among 213 Health Care companies, AVADEL PHARMACEUTICALS PLC is in the bottom 7% for working capital. Working Capital has fluctuated over the past 10 years, ranging from $37M in FY2017 to $248M in FY2020.
Based on SEC 10-K filings.
$85M in FY2024 with a 5-year CAGR of +13.0%.
Improved from $45M to $85M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -20.7%
- 5-Year CAGR
- +13.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 213This company $85.4M Sector average $934.6M
▼
-90.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +13.0%, indicating consistent growth.
- In FY2024, working capital decreased 12.3% year-over-year.
- Ranks #198 out of 213 companies in the Health Care sector.
- Peak working capital was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -28.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $85.4M | -12.3% |
| FY2023 | $97.3M | +116.1% |
| FY2022 | $45.0M | -73.7% |
| FY2021 | $171.5M | -30.9% |
| FY2020 | $248.3M | +435.3% |
| FY2019 | $46.4M | -46.3% |
| FY2018 | $86.5M | +131.0% |
| FY2017 | $37.4M | -68.5% |
| FY2016 | $118.8M | -2.0% |
| FY2015 | $121.2M | +192.1% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026